165 related articles for article (PubMed ID: 9402420)
1. [Mibefradil: a new class calcium inhibitor].
Internist (Berl); 1996 Oct; 37(10 Suppl Mibefradil):1-8. PubMed ID: 9402420
[No Abstract] [Full Text] [Related]
2. [Mibefradil opens up a new class of calcium antagonists. Glasgow, 23 June 1996].
Dtsch Med Wochenschr; 1996 Sep; 121(39 Suppl):1-4. PubMed ID: 9212757
[No Abstract] [Full Text] [Related]
3. Mibefradil (posicor).
Giles TD
Compr Ther; 1997 Nov; 23(11):761-3. PubMed ID: 9360806
[No Abstract] [Full Text] [Related]
4. [Introducing mibefradil--a new T-calcium channel blocker].
Internist (Berl); 1997 Dec; 38(12 Suppl Mibefradil):1-4. PubMed ID: 9437250
[No Abstract] [Full Text] [Related]
5. Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectoris.
Brogden RN; Markham A
Drugs; 1997 Nov; 54(5):774-93. PubMed ID: 9360062
[TBL] [Abstract][Full Text] [Related]
6. Mibefradil: a new twist to the calcium channel antagonist.
Lynn MM
Nurse Pract; 1998 May; 23(5):100, 102-4, 106-7. PubMed ID: 9614683
[No Abstract] [Full Text] [Related]
7. Mibefradil: a new class of calcium-channel antagonists.
Billups SJ; Carter BL
Ann Pharmacother; 1998 Jun; 32(6):659-71. PubMed ID: 9640486
[TBL] [Abstract][Full Text] [Related]
8. [Evolution of antihypertensive therapy with calcium antagonists: the new molecules].
Pirrelli A; Vulpis V
Cardiologia; 1998 Apr; 43(4):357-64. PubMed ID: 9659793
[No Abstract] [Full Text] [Related]
9. The efficacy and safety of mibefradil in subgroups of patients with chronic stable angina pectoris.
Charlon V; Kobrin I
Int J Clin Pract; 1998 Jun; 52(4):257-64. PubMed ID: 9744152
[TBL] [Abstract][Full Text] [Related]
10. Mibefradil, a pharmacologically distinct calcium antagonist.
Ernst ME; Kelly MW
Pharmacotherapy; 1998; 18(3):463-85. PubMed ID: 9620098
[TBL] [Abstract][Full Text] [Related]
11. [The pharmacological and clinical outlook for mibefradil--a new selective T-type calcium channel antagonist].
Eliseev OM
Ter Arkh; 1998; 70(8):87-8. PubMed ID: 9841457
[No Abstract] [Full Text] [Related]
12. Mibefradil--a new calcium-channel blocker.
Med Lett Drugs Ther; 1997 Nov; 39(1013):103-5. PubMed ID: 9391500
[No Abstract] [Full Text] [Related]
13. Mibefradil in the treatment of chronic stable angina pectoris: comparative studies with other calcium antagonists.
Davies GJ; Tzivoni D; Kobrin I
Am J Cardiol; 1997 Aug; 80(4B):34C-39C. PubMed ID: 9286852
[TBL] [Abstract][Full Text] [Related]
14. Diversity of calcium antagonists.
Pitt B
Clin Ther; 1997; 19 Suppl A():3-17. PubMed ID: 9385501
[TBL] [Abstract][Full Text] [Related]
15. Differential properties of mibefradil in hypertension and angina.
Kobrin I
J Hypertens Suppl; 1997 Dec; 15(5):S33-40. PubMed ID: 9481614
[TBL] [Abstract][Full Text] [Related]
16. [Induction of bradycardia by mibefradil in antihypertensive combination therapy].
Wagner J; Ritz E
Dtsch Med Wochenschr; 1998 Apr; 123(17):547. PubMed ID: 9601479
[No Abstract] [Full Text] [Related]
17. Pharmacologic and clinical perspectives on mibefradil: a new T-channel selective calcium antagonist: introduction.
Giles TD
Am J Cardiol; 1997 Aug; 80(4B):1C-3C. PubMed ID: 9286847
[No Abstract] [Full Text] [Related]
18. Long-term antianginal and antiischemic effects of mibefradil, the novel T-type calcium channel blocker: a multicenter, double-blind, placebo-controlled, randomized comparison with sustained-release diltiazem.
Davies GJ; Kobrin I; Caspi A; Reisin LH; de Albuquerque DC; Armagnijan D; Coelho OR; Schneeweiss A
Am Heart J; 1997 Aug; 134(2 Pt 1):220-8. PubMed ID: 9313601
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic angina pectoris with combination mibefradil and beta-blocker therapy.
Alpert JS
Clin Cardiol; 1998 Feb; 21(2):129. PubMed ID: 9491954
[No Abstract] [Full Text] [Related]
20. Mibefradil: a selective T-type calcium antagonist.
Massie BM
Am J Cardiol; 1997 Nov; 80(9A):23I-32I. PubMed ID: 9375939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]